|

CRX100 suspension for infusion Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BioEclipse Therapeutics1

Indications

  • Liver Disease1
  • Malignant Melanoma1
  • Osteosarcoma1
  • Triple Negative Breast Cancer1
  • Epithelial Ovarian Cancer1

Scottsdale, Arizona1 trial

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

HonorHealth Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.